Effects of strict COVID-19 lockdown on patients with obsessive-compulsive disorder compared to a clinical and a nonclinical sample.


Journal

European psychiatry : the journal of the Association of European Psychiatrists
ISSN: 1778-3585
Titre abrégé: Eur Psychiatry
Pays: England
ID NLM: 9111820

Informations de publication

Date de publication:
01 06 2023
Historique:
medline: 23 6 2023
pubmed: 1 6 2023
entrez: 31 5 2023
Statut: epublish

Résumé

Symptoms of obsessive-compulsive disorder (OCD) have been reported to increase during the COVID-19 lockdowns because of the hygiene requirements related to the pandemic. Patients with adjustment disorder (AD) may, in turn, represent a vulnerable population for identifiable stressors. In this study, we aimed at assessing potential symptoms changes in OCD patients during the lockdown in comparison with AD patients as well as versus healthy controls (HC). During the COVID-related lockdown, we enrolled 65 patients and 29 HC. Participants were tested with four clinical rating scales (Yale-Brown obsessive-compulsive scale and Brown Assessment of Beliefs Scale for OCD patients; Beck Depression Inventory-II and State-Trait Anxiety Inventory-Y for each group) that had been also administered just before the Italian lockdown. Our results showed that during the lockdown: (i) the symptoms of depression and anxiety increased in all groups, but this increase was most pronounced in HC ( The lockdown-induced psychological distress apparently changed the characteristics and the pattern of OCD symptoms expression but not their overall severity. This evidence confirms the heterogeneity and changing nature of OCD symptoms, strongly depending on the environmental circumstances.

Sections du résumé

BACKGROUND
Symptoms of obsessive-compulsive disorder (OCD) have been reported to increase during the COVID-19 lockdowns because of the hygiene requirements related to the pandemic. Patients with adjustment disorder (AD) may, in turn, represent a vulnerable population for identifiable stressors. In this study, we aimed at assessing potential symptoms changes in OCD patients during the lockdown in comparison with AD patients as well as versus healthy controls (HC).
METHODS
During the COVID-related lockdown, we enrolled 65 patients and 29 HC. Participants were tested with four clinical rating scales (Yale-Brown obsessive-compulsive scale and Brown Assessment of Beliefs Scale for OCD patients; Beck Depression Inventory-II and State-Trait Anxiety Inventory-Y for each group) that had been also administered just before the Italian lockdown.
RESULTS
Our results showed that during the lockdown: (i) the symptoms of depression and anxiety increased in all groups, but this increase was most pronounced in HC (
CONCLUSIONS
The lockdown-induced psychological distress apparently changed the characteristics and the pattern of OCD symptoms expression but not their overall severity. This evidence confirms the heterogeneity and changing nature of OCD symptoms, strongly depending on the environmental circumstances.

Identifiants

pubmed: 37258286
doi: 10.1192/j.eurpsy.2023.2416
pii: S0924933823024161
pmc: PMC10304986
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e45

Références

J Psychiatr Res. 2022 May;149:114-123
pubmed: 35272208
Eur Psychiatry. 2021 Jun 08;64(1):e45
pubmed: 34100343
Psychol Med. 2021 Apr;51(6):1054-1056
pubmed: 32423496
Diagnostics (Basel). 2022 Apr 12;12(4):
pubmed: 35454005
Arch Gen Psychiatry. 1989 Nov;46(11):1006-11
pubmed: 2684084
Am J Psychiatry. 1998 Jan;155(1):102-8
pubmed: 9433346
J Nerv Ment Dis. 2021 Apr 1;209(4):256-264
pubmed: 33625069
Lancet Psychiatry. 2020 Jul;7(7):570-572
pubmed: 32563299
Int J Environ Res Public Health. 2021 Jul 12;18(14):
pubmed: 34299871
Nat Rev Dis Primers. 2019 Aug 1;5(1):52
pubmed: 31371720
Brain Behav Immun. 2020 Jul;87:100-106
pubmed: 32353518
Brain Behav Immun. 2020 Jul;87:40-48
pubmed: 32298802
Psychiatry Res. 2020 Jun;288:112966
pubmed: 32334276
J Anxiety Disord. 2020 May;72:102232
pubmed: 32408047
Front Psychiatry. 2020 Jul 21;11:720
pubmed: 32793008
Trends Psychiatry Psychother. 2021 Apr-Jun;43(2):81-84
pubmed: 33503168
Eur Psychiatry. 2020 Sep 28;63(1):e87
pubmed: 32981568
J Biomed Inform. 2010 Oct;43(5):831-43
pubmed: 20601124
Front Psychiatry. 2020 Dec 16;11:581426
pubmed: 33391049
Psychiatry Res. 2020 Sep;291:113213
pubmed: 32535508
J Psychiatr Res. 2022 Oct;154:293-299
pubmed: 35964348
J Obsessive Compuls Relat Disord. 2021 Jan;28:100610
pubmed: 33288995
J Obsessive Compuls Relat Disord. 2021 Apr;29:100626
pubmed: 33520614

Auteurs

Giordano D'Urso (G)

Section of Psychiatry, Department of Neuroscience, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.

Alfonso Magliacano (A)

IRCCS Fondazione Don Carlo Gnocchi ONLUS, Florence, Italy.

Bernardo Dell'Osso (B)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
Department of Psychiatry and Behavioral Sciences, Bipolar Disorders Clinic, Stanford University, Stanford, CA, USA.
"Aldo Ravelli" Center for Nanotechnology and Neurostimulation, University of Milan, Milan, Italy.

Hekla Lamberti (H)

Section of Psychiatry, Department of Neuroscience, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.

Adalgisa Luciani (A)

Section of Psychiatry, Department of Neuroscience, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.

Teresa S Mariniello (TS)

Section of Psychiatry, Department of Neuroscience, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.

Mattia V Pomes (MV)

Section of Psychiatry, Department of Neuroscience, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.

Lorenza M Rifici (LM)

Section of Psychiatry, Department of Neuroscience, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.

Felice Iasevoli (F)

Section of Psychiatry, Department of Neuroscience, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.

Andrea de Bartolomeis (A)

Section of Psychiatry, Department of Neuroscience, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH